Home Tags Infection Control

Infection Control Related Content

sinovac COVID-19 variant, variant

WHO gives emergency approval to Sinovac COVID-19 vaccine

The World Health Organisation (WHO) has given emergency approval to the Sinovac COVID-19 vaccine - because there is ongoing "access inequity" for countries in the Global South.
focus on One Health

COVID-19 & the urgent case for a greater focus on One Health

Frances Goodrum, Head of External Affairs, Brooke Action for Working Horses and Donkeys, turns our attention to COVID-19 and the urgent case for a greater focus on One Health.
safe nhs environments

Safe NHS environments: For patient, clinician & support worker

Kate Edwards, Director at Intelligent Infection Control Services Limited, LumiBio, underlines the importance of creating safe environments for the patient, clinician & support worker in the NHS.
COVID-19 test kit

Rapid COVID-19 test kit receives scientific seal of approval

Researchers from Simon Fraser University have approved a faster, cheaper COVID-19 test kit that could expand more widespread rapid testing.
origins of COVID-19, wuhan covid

US pushes for investigation into origins of COVID-19

President Biden asked US intelligence agencies to begin investigating the origins of COVID-19 yesterday (26 May) - the international WHO team were unable to access all available data in their March trip to Wuhan.
logistics and supply chain

Logistics & supply chain will win the COVID-19 war

Professor Richard Wilding argues that biochemistry is winning the battle against coronavirus, but logistics and supply chain will win the war.
COVID impact on society, healthcare

COVID-19 and its impact on society

European Public Health Association Executive Director, Dineke Zeegers Paget, updates us about COVID-19 and its impact on society, public health, healthcare and equitable access to vaccines.
indian variant more infectious, kent

REACT study: Unclear if Indian variant more infectious than Kent variant

The REACT study suggests that scientists don't know if the Indian variant is more infectious than the Kent variant - largely responsible for the winter wave of deaths.
antibody response

Pfizer vaccine produces greater antibody response when given at 12 weeks

A new study has found that the second dose of the Pfizer vaccine produces a 3.5-times greater antibody response when given at 12 weeks, compared to three weeks.
endothelium and long COVID, long COVID

Scientists investigate link between endothelium and Long COVID

Scientists examining how COVID impacts the entire human body, not just the lungs, believe that there could be a link between the endothelium and Long COVID.
SARS-CoV-2 variant

Global bioinformatics surveillance: SARS-CoV-2 variant detection tests

Shiao Yee, Marketing Communications Manager, Novacyt Group, discusses how global bioinformatics surveillance drives innovation in SARS-CoV-2 variant detection tests.
antibody deficiencies

Study examines immune responses to COVID in patients with antibody deficiencies

A new study aims to explore the immune response to COVID-19 infection and vaccination in patients with antibody deficiencies.

COVID-19 vaccine does not damage placentas

Researchers from Northwestern Medicine have studied the placentas from patients who received the COVID-19 vaccine during pregnancy and found no evidence of damage.
the covid-19 crisis

Testing must go hand-in-hand with vaccines to come out of the crisis

COVID-19 testing must go hand-in-hand with the vaccines in order for the UK to come out of the crisis successfully.
covid-19 severity

Researchers given £5m to understand COVID-19 severity in India and the UK

Four research partnerships have been awarded £5 million to provide a deeper understanding of COVID-19 severity in India and the UK.
hand dermatitis

Two-thirds of the public have hand dermatitis due to rigorous hand washing

More than two-thirds of the public may have hand dermatitis due to stringent handwashing during the COVID-19 pandemic.
covid-19 vaccine trials 

Only 41% of people are willing to sign up for COVID-19 vaccine trials

New research from the University of Birmingham shows that only 41% of people would be willing to sign up for COVID-19 vaccine trials.
future viruses

Screening healthcare workers could serve as warning system for viruses

Researchers have suggested that data from healthcare workers could be used to rapidly estimate the severity of future viruses.
COVID-19 conspiracy

Social media users more likely to believe COVID-19 conspiracy theories

A study by Annenberg Public Policy Center (APPC) researchers has found that users of conservative and social media are more likely to believe COVID-19 conspiracy theories.

Using UVC light on disinfectants makes them safer to use

A new study from the University of Waterloo has found that applying UVC light to common disinfectants makes them safer to use against COVID-19.

Follow Open Access Government